Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Akzo Nobel on sale of the business in Carbide Sweden to SKW
Mandate

Vinge advises Akzo Nobel on sale of the business in Carbide Sweden to SKW

December 20, 2010

Vinge is advising Akzo Nobel Sweden Finance AB (publ) in connection with the divestment of the business in the wholly-owned subsidiary Carbide Sweden AB to the German specialist chemicals company SKW Stahl-Metallurgie Holding AG. Carbide Sweden produces and markets calcium carbide, a raw material used in the production of acetylene gas, which is used for welding and other applications. Carbide is also used in steel production.

The Vinge team includes partner Daniel Rosvall and associate Peter Sundgren (M&A), partner Thomas Sjöberg, counsel Johan Cederblad and associate Daniel Unger (Real Estate & Environmental), associates Jenny Dangré, Christian Hybbinette and My Muratori (General Corporate), associate Per Westman (Employment) and counsel Per Karlsson (EU & Antitrust).

Related

Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of MedMera Bank AB

 Vinge has advised Morrow Bank AB (publ) in conjunction with the acquisition of all shares in MedMera Bank AB from Kooperativa Förbundet for a total consideration of SEK 1,960 million. The transaction positions Morrow Bank as a leading Nordic platform in consumer finance with combined gross loans of SEK 28.2 billion.
March 24, 2026

Vinge advises NEWS, a portfolio company of Litorina, in connection with the sale of Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG

 Vinge advises Northern Environmental and Water Solutions AB (“NEWS”), a portfolio company of Litorina, in connection with the sale of the operating subsidiaries Skandinavisk Kommunalteknik, FANN VA-Teknik and Alunda Polyeten to Wienerberger AG (Vienna Stock Exchange: WIE). The transaction is expected to be completed in Q2 2026.
March 24, 2026

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

 Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026